CFO SpotlightsCareers of chief financial officers, from the filings. Records as of October 28, 2026
  1. CFO Spotlights
  2. Profiles
  3. Andrew D. Dickinson

Profile

Andrew D. Dickinson

Chief Financial Officer (Principal Financial Officer), Gilead Sciences

In the seat. First published here October 28, 2026; built from records as of October 28, 2026.

Andrew D. Dickinson signed the annual report of Gilead Sciences as Chief Financial Officer (Principal Financial Officer); the report was filed on February 24, 2026, the most recent filing in the record that ties Andrew D. Dickinson to the seat.1

Seats

The seat in the record

CompanyTitle as filedStandingFilings
Gilead Sciences (GILD)
Biological Products, (No Diagnostic Substances)
Chief Financial Officer (Principal Financial Officer)In the seat1

Company names link to the company's page in the record at CFO Tribune, which holds the seat history.

The record

Filing by filing, latest first

  1. February 24, 202610-K filed

    Andrew D. Dickinson signed the annual report of Gilead Sciences on Form 10-K as Chief Financial Officer (Principal Financial Officer), filed February 24, 2026.

    /s/ ANDREW D. DICKINSON Chief Financial Officer February 24, 2026 Andrew D. Dickinson (Principal Financial Officer)

    [1] Annual report on Form 10-K by Gilead Sciences, filed with the SEC on February 24, 2026. Read the filing. The record at CFO Tribune.

Sources

Sources

  1. Annual report on Form 10-K, Gilead Sciences. U.S. Securities and Exchange Commission, EDGAR, filed February 24, 2026. sec.gov; record.

Corrections and removal

If a line here is wrong, or Andrew D. Dickinson wants this profile taken down, write to corrections@cfospotlights.com. Corrections are made on the page with a dated note; removal requests are answered within 72 hours. The underlying filings stay public at the SEC.